This is Molly Hemingway, encouraging you to listen to my favorite podcast, issues, etc.

Every day you get in-depth interviews with host Todd Wilkin asking expert guests, substantive, thought-provoking questions on all of the important news and issues of our day.

The expert guests are in culture, law, ethics, philosophy, theology,

and apologetics. Expert guests? Expansive topics. Always extolling Christ. Issues, etc. Well, right before the government shut down, the Food and Drug Administration did something that may prove to be very significant.

And really in exactly the opposite direction that it should be going, it decided to approve the generic version

of MIF-Pristone, which is the abortion pill. What does that mean? And how does that represent

simply another step in the wrong direction for the FDA and the abortion pill? Welcome back to issues et cetera. I'm Todd Wilkin, joining us to talk about the FDA and the abortion pill. Welcome back to Issues, Et cetera.

I'm Todd Wilkin,

joining us to talk about the FDA and abortion pills,

Marjorie Dan & Felser,

president of Susan B. Anthony Pro-Life America,

author of a recent op-ed for USA Today

titled FDA's Abortion Pill Approval

is a reckless decision that will harm women and babies.

Marjorie, welcome back.

It's been a while. It's good to hear from you, Todd.

Give us a history, if you would, of the Food and Drug Administration's reckless course on the abortion pill.

Yes. When I was on the hill 100 years years ago and a very upsetting move in the early

90s, maybe mid-90s, the abortion pill, Mephypristone, which is given in two different doses,

two different types of medications to induce an abortion medically, chemically, was approved.

It was approved for about 10 weeks. And then later,

it was approved a little bit for a couple more weeks. Okay. So that all was, we knew in the

...